Target intelligence / Profile preview

Genomic DNA regulatory elements bound by OCT4, SOX2, and KLF4 (OSK-bound regulatory elements)

Target
OSK-bound regulatory elements
Molecular classification
Genomic DNA, Regulatory element, Enhancer, Transcription factor, Other
01

Overview

Genomic DNA regulatory elements bound by OCT4, SOX2, and KLF4 represent the core transcriptional circuitry responsible for maintaining the undifferentiated state and self-renewal capacity of pluripotent stem cells (Boyer et al., 2005; Cell). These elements, primarily enhancers and promoters, serve as docking sites for the transcription factors OCT4 (POU5F1), SOX2, and KLF4, which cooperatively regulate the expression of genes essential for stemness, such as NANOG (Chambers & Tomlinson, 2009; Development). In a therapeutic context, these genomic regions are critical for cellular reprogramming into induced pluripotent stem cells (iPSCs) (Takahashi & Yamanaka, 2006; Cell). However, their dysregulation is frequently observed in various cancers, where they drive the cancer stem cell phenotype, leading to tumor progression, chemoresistance, and metastasis (Young, 2011; Cell). While these DNA elements themselves are not traditional targets for small molecule drugs, they are central to gene therapy and genome editing strategies aimed at modulating cell fate or treating malignancies. The precise control of these elements is vital, as improper activation can lead to the formation of teratomas or other off-target developmental effects.

Other names
OSK binding sitesPluripotency-associated enhancersOSK-regulated genomic regionsOSK-bound enhancersPluripotency circuitry elements
02

Mechanism of action

Modulation of gene expression through the recruitment of transcriptional co-activators, such as p300 and Mediator, and chromatin remodeling complexes to specific genomic loci to maintain stemness or induce reprogramming.

03

Biological functions

Cell proliferationCell differentiationPluripotency maintenanceCellular reprogrammingTranscriptional regulationOther
04

Disease associations

CancerOther
05

Safety considerations

Risk of tumorigenesisTeratoma formationOff-target gene activationGenomic instabilityLoss of cell identity
06

Biomarkers

OCT4 expressionSOX2 expressionKLF4 expressionNANOG expressionChromatin accessibility at OSK sites

Beyond the preview

Go deeper on Genomic DNA regulatory elements bound by OCT4, SOX2, and KLF4 (OSK-bound regulatory elements).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomic DNA regulatory elements bound by OCT4, SOX2, and KLF4 (OSK-bound regulatory elements).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call